Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry

Medicine & Life Sciences

• Liquid Chromatography 100%
• Mass Spectrometry 86%
• Parkinson Disease 80%
• Metabolomics 24%
• Biomarkers 19%
• Metabolome 16%
• Bile Acids and Salts 15%
• Acids 11%
• Steroids 11%
• acylcarnitine 10%
• Antiparkinson Agents 10%
• Amides 8%
• Levodopa 8%
• Workflow 8%
• Phenylalanine 8%
• Glutamine 7%
• Caffeine 7%
• Metabolic Networks and Pathways 7%
• Microbiota 7%
• Tyrosine 6%
• Fatty Acids 6%
• Datasets 5%
• Linear Models 5%
• Multivariate Analysis 5%
• Hormones 5%
• Amino Acids 5%
• Genome 5%
• Elderly 4%
• Regression Analysis 4%
• Lipids 4%
• Logistic Models 4%
• Morbidity 4%
• Mortality 3%
• Therapeutics 3%
• Pharmaceutical Preparations 3%